(Q33375557)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17569122%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17569122%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

0 references

1 reference

Chaiyut Charoentum

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17569122%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sumitra Thongprasert

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17569122%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Busyamas Chewaskulyong

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17569122%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sutthirak Munprakan

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17569122%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

English

0 references

publication date

1 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17569122%20AND%20SRC:MED&resulttype=core&format=json

World Journal of Gastroenterology

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17569122%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17569122%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17569122%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

2852-2854

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17569122%20AND%20SRC:MED&resulttype=core&format=json

Phase II study of erlotinib in patients with advanced biliary cancer

31 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4395638

Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4395638

Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4395638

Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4395638

Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4395638

Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4395638

Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4395638

A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4395638

Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4395638

Comparison of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4395638

Eastern cooperative oncology group experience with chemotherapy for inoperable gallbladder and bile duct cancer

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17569122

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3748/WJG.V13.I20.2852

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17569122%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17569122%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

PubMed publication ID

17569122

1 reference